MRI-Guided radiation: a sharper weapon against prostate cancer?
NCT ID NCT00913939
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to deliver high-dose radiation to prostate tumors using real-time MRI guidance. It includes two groups: men whose prostate cancer has returned after prior radiation, and men with advanced cancer receiving standard external beam radiation plus this boost. The goal is to see if MRI guidance improves accuracy and tumor targeting in up to 500 patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MRI-guided HDR brachytherapy
- What this could lead to
- If successful, this approach could make prostate cancer treatment more precise, potentially reducing side effects and improving outcomes for patients with recurrent or advanced disease.
- What could go wrong
- This is a pilot study focused on technical performance, not yet proven to improve survival. The procedure is complex and may carry risks like bleeding, infection, or urinary problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY RECURRENT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Health Network, Princess Margaret Hospital
RECRUITINGToronto, Ontario, M5G 2M9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.